In the Research Letter “Characterizing Kaiser Permanente Southern California’s Experience With the California End of Life Option Act in the First Year of Implementation,”¹ published online December 26, 2017, there was an error in the number of patients reported in the Results section. Where it previously read “Nearly 130 (74%) of patients who received the EOLOA drugs ingested them and died within a median of 9 days after the prescription was written,” it now reads “Sixty-eight (74%) of the 92 patients who received the EOLOA drugs ingested them and died within a median of 9 days after the prescription was written.” This article was previously corrected for a typographic error in the study flow chart.²

在2017年12月26日在线发表的研究信函“在执行的第一年中刻画了南加州凯撒永久性公司在《加州生命终止选择法》方面的经验” ¹，结果部分报告的患者人数有误。先前的记录是：“在开出处方后的9天内，有近130名（74％）接受EOLOA药物的患者摄入并死亡，现在改为：“ 92名患者中有68（74％）服用EOLOA药物的人将其摄入并在处方写入后9天内死亡。” 先前已对本文研究流程图中的印刷错误进行了更正。^2个